Pregnancy is a physiological state with a great demand of energy and nutrients in mammals and is characterized by hyperphagia, increase in fat mass, hyperleptinemia, and central resistance to leptin. In order to evaluate whether pregnancy is also a state of leptin resistance at the periphery, we studied the response to leptin in the liver and subcutaneous adipose tissue (SAT). We demonstrated reduced levels of phosphoryalated signal transducer and activator of transcription 3 (p-STAT3) and phosphorylated protein kinase B (p-AKT) after intravenous leptin in both tissues in mid-term pregnant rats (G13) and a restored response in late pregnancy (G18). As underlying mechanisms of the peripheral leptin resistance of mid-gestation we found decreased leptin receptor b (LepRb) mRNA levels and increased content of suppressor of cytokine signaling 3 (SOCS3). Furthermore, we demonstrated that in G13 rats the main lipogenic molecules and activity (sterol regulatory element binding transcription protein 1 (SREBP-1) and fatty acid synthase (FAS)) were elevated in the liver and SAT, and the molecules involved in β-oxidation (peroxisome proliferator activated receptor α (PPARα) and carnitine palmitoyltransferase 1 (CPT-1)) were reduced, as it happens in early pregnancy. In G18, the opposite pattern is observed. This probably reflects that in G13 the peripheral resistance to the hyperleptinemia might help maintaining the lipogenic metabolism of early pregnancy. In contrast, the recovery of the response to leptin in late pregnancy would favor a catabolic metabolism. Finally, using a pseudogestation model we showed that progesterone and prolactin are not involved in the gestational peripheral leptin resistance. In conclusion, during mid-pregnancy a state of leptin resistance is also exerted at the periphery, and is probably involved in the characteristic lipid regulation of this physiological state.
Introduction
For female mammals, gestation constitutes a physiological state of great demand of energy and nutrients. In order to ensure the development of the fetus and the maternal requirements, coordinated adaptations occur in all organs and systems of the mother. One of the most relevant regulatory processes is the increase in food intake, and the synthesis and deposit of lipids [1] [2] [3] [4] [5] . Pregnancy is characterized by hyperphagia, hypertriglyceridemia, and increased fat stores, in parallel with hyperleptinemia, which indicates leptin resistance [5] [6] [7] [8] [9] . We and other authors have already demonstrated that gestation is a state of central resistance to leptin [5] [6] [7] [8] [9] , as well as to other anorectic factors [10] , which allows the anabolic metabolism in the mother.
Although leptin's centrally mediated actions seem to dominate in regulating whole-body energy balance and metabolism [11, 12] , the existence of leptin receptors in the periphery suggests that leptin also exerts direct effects on these organs. Mounting evidence indicates that peripheral leptin receptors are directly involved in regulating fuel metabolism in target tissues such as skeletal muscle, adipose tissue, liver, and pancreas, as well as in other functions such as angiogenesis, immune function, reproductive physiology, and bone formation [13] [14] [15] . Furthermore, numerous data indicate that one of the main roles of peripheral leptin receptors might be controlling cellular lipid balance directly at the target organs by increasing β-oxidation and lipolysis and decreasing fatty acid synthesis [16] [17] [18] [19] [20] . Of note, mice with a hepatocyte-specific loss of leptin receptor showed increased lipid accumulation in the liver together with increased levels of very low density lipoproteins (VLDL) triglycerides [21] . On the other hand, the reduction of the expression of leptin receptors specifically in white adipose tissue leads to increased adiposity and dyslipidemia [22] , highlighting the role of liver and adipose tissue leptin receptors in fat metabolism regulation by leptin actions exerted directly on these organs.
Leptin binds and activates several types of leptin receptors (LepR) [23, 24] . LepRb, the long and active leptin receptor, does not contain intrinsic enzymatic activity, but instead signals via a noncovalently associated tyrosine kinase of the Jak family (Jak2) [23, 25, 26] , and the recruitment and activation of various downstream signaling molecules, including signal transducer and activator of transcription (STAT) transcription factors, insulin-receptor-substrate proteins, phosphoinositide-3-kinase (PI3K), the Ras-Raf mitogen-activatedprotein-kinase, and AMP-activated protein kinase (AMPK) [23, 25, 26] . Nevertheless, it has been established that STAT3 plays a major role in leptin's action [23, [25] [26] [27] [28] [29] . Furthermore, following a STAT3-dependent production, suppressor of cytokine signaling 3 (SOCS3) mediates an inhibition of LepRb-STAT3 signaling [30, 31] . In obesity, a state of leptin resistance has been demonstrated not only at the central level but also in peripheral organs (liver, skeletal muscles, and heart). In the periphery, direct actions of the hormone are frequently inhibited due to upregulation of negative leptin regulators, like SOCS3, a reduction in LepRb, and a decrease in activation of AMPK [32] [33] [34] .
The increase in body weight, fat synthesis, and fat deposit in the presence of hyperleptinemia indicates that gestation is a state of transitory resistance to leptin, which allows the acquisition of energy deposits for reproduction. We have previously demonstrated that during pregnancy there is central leptin resistance [5] . In this manuscript, we studied whether leptin resistance is also exerted at the periphery, favoring the synthesis of lipids. We focused on liver and subcutaneous adipose tissue (SAT), two relevant organs in lipid metabolism. As gestation is composed of an anabolic phase (early and mid-term) and of a late catabolic period, we determined the response to leptin administration, assessed as phosphorylation levels of STAT3 and (AKT) in liver and SAT in mid (G13) and late (G18) pregnancy. We have already reported hyperleptinemia and central leptin resistance in these two gestational ages [5] . To dissect out the possible mechanisms underlying leptin resistance, we determined the mRNA levels of the long active form of leptin receptor (LepRb) and the content of SOCS3. We also studied in both tissues key molecules of lipid metabolism, particularly those involved in "de novo" fatty acid synthesis and β-oxidation in early (G7), mid (G13), and late gestation (G18). These two processes are closely regulated by leptin. Finally, we assessed the possible involvement of progesterone and prolactin in the peripheral leptin resistance with a model of pseudogestation that we have already used [5] .
Our results demonstrate a biphasic response to the hyperleptinemia of pregnancy in liver and SAT. A blunted response in midpregnancy reflects resistance to leptin in peripheral organs. This might contribute to maintain the enhanced lipogenesis and fat deposit, already observed in early gestation, despite the progressive hyperleptinemia; a recovery of the response in late pregnancy probably favors a catabolic metabolism. As putative mechanisms underlying the resistance to leptin, we have observed a reduction in LepRb mRNA and an increase in SOCS3 in these tissues. Finally, progesterone and prolactin do not seem to be involved in this mid-term peripheral leptin resistance of gestation.
Material and methods

Animals
Adult female Sprague-Dawley rats (250-300 g) were housed at 23
• C in a cycle of 12 h light/12 h dark. Animals were allowed free access to standard laboratory pellets of rat chow and tap water. The estrus cycle was monitored by daily cytological examinations of vaginal smears. Proestrus females were housed overnight with a male rat, and mating was confirmed by the presence of sperm in the vaginal smear the following morning. In this study, we used rats at 7 (G7), 13 (G13), and 18 (G18) days of pregnancy. Diestrus-I nonpregnant rats were considered as control (C). To obtain pseudopregnant rats, proestrus females were housed overnight with a vasectomized male rat. Daily vaginal smears were monitored throughout pseudopregnancy to confirm that the estrus cycle was being held in continual diestrus. Rats of 9 and 18 days of pseudopregnancy were employed (P9, P18). In P18 rats, hormonal levels returned to nonpregnancy levels and the cyclicity is restored. The protocols were approved by the Ethics Committee of the University of Santiago of Compostela, and experiments were performed in agreement with the rules of Laboratory Animal Care and International Law on Animal Experimentation.
Samples collection
All tissue samples of hepatic and SAT were frozen immediately into dry ice and maintained at -80 • C until processed. The animals from each experiment were killed on the same day at the same hours (0900 h-1100 h).
Intravenous treatment with leptin
Animals were anesthetized with an intraperitoneal injection of ketamine-xylazine, 50 mg/kg, (Ketolar-Barke-Davis-Morris-Plains, Rompun-Bayer, Kiel, Germany). A cannula (PE50, BectonDickinson & Co., Oxford, UK; connected to Silclear, DeganiaSilicone) was inserted into the jugular vein of the animals (C, G13 G18, P9, and P18). After surgery, rats were housed individually, and weight gain was monitored daily for 5 days to ensure full recovery. On the day of the experiment, C, G13, G18, P9, and P18 rats (which had been maintained in a state of fasting overnight to reduce endogenous leptin concentrations) received an injection of either leptin (100 μg/rat dissolved in 100 μL of distilled water, Peprotec-Inc., London, UK) or vehicle into the jugular vein. This dose of leptin was already used by us and others and efficiently and successfully activates the STAT3 signaling cascade [5, 35] . One hour after the intravenous (iv) treatment, animals were killed and the liver and adipose tissues were removed to determine p-STAT3 ( Table S1 ). Membranes were then washed and incubated with secondary antibodies (HRP-conjugated, Amersham, Buckinghamshire, UK) at room temperature, and the proteins of interest on immunoblots were detected by SuperSignal chemiluminescent substrate (Pierce, Rockford, IL) and X-ray films (Amersham). Signal intensities were quantified using ImageJ software (National Institutes of Health, Bethesda, MD). The results were normalized using α-tubulin levels. In the case of SREBP-1, the antibody detected the processed (68 kD) and nonprocessed protein (120 kDa).
Messenger RNA isolation and RT-PCR
Total RNA was isolated by Trizol (Invitrogen) and was quantified by optical density at 260 nm. The messenger RNA (mRNA) levels of LepRb [6, 36] , sterol regulatory element binding transcription protein 1 (Srebp-1), fatty acid synthase (Fas), peroxisome proliferator activated receptor alpha (Ppar-α), and carnitine palmitoyltransferase 1 (Cpt-1L) in liver and adipose tissue of nonpregnant, pregnant, and pseudo-pregnant rats were assessed by RT-PCR using specific primers as shown in Supplementary Table S2 . One microgram of total RNA was reverse transcribed into complementary DNA in a final volume of 30 μl with Moloney murine leukemia virus reverse transcriptase (Gibco BRL, Invitrogen), Random Primers (Gibco BRL, Invitrogen), dNTPs (Gibco BRL, Invitrogen), Rnase Out (Gibco BRL, Invitrogen), MgCl and first stand buffer (Gibco BRL, Invitrogen), incubated at 37
• C for 50 min, 42
• C for 15 min, and the enzyme was inactivated by heating at 95
• C for 5 min [6] . Complementary DNA was amplified with 3 μl of the RT product, using specific sets of primers (Supplementary Table S2 ), dNTPs (Gibco BRL, Invitrogen), Taq polymerase (Gibco BRL, Invitrogen), 10x PCR buffer, and MgCl. Temperature and times used were 34 cycles at 94 Hprt and LepRb has been published elsewhere [6, 36] . The amplified products were resolved in a 2% agarose gel and quantified by densitometry using the ImageJ software (National Institutes of Health, Bethesda, MD). All PCR products were digested with specific restriction enzymes [6, 36] . RT-PCR without reverse transcriptase was also performed as a negative control. Hprt amplification was used as an internal control. Signal intensities were quantified using amplifications that were carried out in a thermal cycler (Eppendorf, Hamburg, Germany).
Activity assays
Tissue samples were homogenized in ice-cold, phosphate buffer with protease inhibitors. The homogenate was then centrifuged at 100,000 × g at 4
• C for 1 h. The fluid was quantified for protein content.
Carnitine palmitoyltransferase-1 activity assay [39, 40] ).
Progesterone immunoassay
Serum progesterone concentrations were measured in C, G13, G18, P9, and P18 rats using a commercially available ELISA kit, DE1561 (Demeditec-Diagnostics, GmbH-Germany). Serum samples were subjected to an extraction procedure for steroids to achieve more specificity in the assay. Briefly, 2 mL of diethyl ether were added to 500 μL of serum. After shaking for 15 min, and centrifugation at 2000 rpm (4 • C, 5 min) samples were put into freezer (-20 • C) until the lower (aqueous) phase was frozen. Then, the upper phase was decanted and the lower phase was dried under a nitrogen stream. Finally, 100 μL of 0 mg/mL standard hormone solution was added to the precipitate. The coefficients of intra-assay and interassay variance were 12% and 6.99%, respectively. The mdd was 0.045 ng/mL, as provided by the manufacturer, and the detected differences in concentration were 12 pg/mL.
Triglyceride levels
Serum triglyceride concentrations were measured in C, G13, and P9 rats using a commercially enzymatic colorimetric method, endpoint analysis, Triglycerides MR (Linear Chemicals SL. Barcelona); sensitivity: 0.005 mmol/L (0.47 mg/dL), linearity up to 9.04 mmol/L (800 mg/dL). Coefficients of within-run and between-run variance were 0.58% and 1.84%, respectively. 
Statistical analysis and data presentation
Prior to all statistical analyses, data were examined for assumptions of normality of variance using the Kolmogorov-Smirnov test. Statistically significant differences in the parameters studied between two experimental groups were determined by an unpaired t-test. Differences in more than two groups were determined by two-way ANOVA (Minitab 17.1.0) (with gestational age and leptin treatment as main factors), followed by a post hoc Bonferroni test or by a Fisher test; or by one way ANOVA (progesterone levels), followed by a post hoc Fisher test. Data were expressed as mean ± SEM. Protein and mRNA levels were represented as percentage change in relation to control values (nonpregnant rats). The significance level was set at P < 0.05.
Results
Peripheral leptin resistance during pregnancy
Mid-and late-pregnant rats are hyperleptinemic and display central resistance to leptin [1, [5] [6] [7] [8] . In order to demonstrate the existence of leptin resistance directly exerted on peripheral organs, we administered leptin iv (100 μg/rat) to pregnant (G13 and G18) and nonpregnant rats (C), and we studied the phosphorylation levels of STAT3 and AKT in liver and SAT, two main metabolic target tissues of leptin. Leptin administration to control rats increases pSTAT3 and pAKT levels in liver and SAT ( Figure 1A : P = 0.001, 1B: P = 0.001, 1C: P = 0.001, and 1D: P = 0.001). In contrast, we show a blunted response to leptin in both peripheral tissues in G13 animals (Figure 1A-D) and a recovery of the response in late gestation (G18) ( Figure 1A : P = 0.024, 1B: P = 0.001, and 1C: P = 0.002, relative to G18 rats treated with vehicle). Furthermore, a lower basal level of activated STAT3 and AKT (pSTAT3 and pAKT) was observed in G13 liver and SAT, respectively, vs nonpregnant controls (Figure 1A: P = 0.001 and 1D: P = 0.036). Also, leptin-induced pAKT levels in liver and leptin-induced pSTAT3 content in adipose tissue were lower in G13 than those observed in vehicle-treated animals ( Figure 1B : P = 0.001 and 1C: P = 0.007). All these findings suggest the existence of a resistance to leptin exerted directly on liver and adipose tissue during mid-term pregnancy, with a restoration of the response in late gestation.
Mechanisms underlying leptin resistance during mid-pregnancy in liver and adipose tissue
To dissect out the possible mechanisms underlying the state of peripheral leptin resistance, we determined in liver and SAT the mRNA levels of the long form of the leptin receptor (LepRb) and the content of SOCS3 protein in mid-pregnancy (G13). We found a significant decrease of LepRb mRNA levels and an increased content of SOCS3 in liver and SAT from G13 rats in relation to nonpregnant animals ( Figure 2A : P = 0.020; 2B: P = 0.002; 2C: P = 0.024; 2D: P = 0.021). Furthermore, LepRb mRNA levels were already reduced at 7 days of gestation (G7) in SAT, but not in liver ( Figure 2B : P = 0.005). In order to gain further insight into the restored response to leptin in late gestation, we also determined LepRb mRNA levels in livers from G18 rats. We found a significant increase in those levels in relation to G13 (Figure 2A : P = 0.020). 
Lipid metabolism in liver and subcutaneous adipose tissue
Since we have reported in the present work a biphasic response to leptin during pregnancy in liver and SAT, we then studied relevant molecules known to be regulated by leptin and involved in the synthesis or β-oxidation of lipids in early, mid, and late gestation (G7, G13, and G18) in both tissues. In particular, we determined the level of expression of SREBP1 and Fas, together with fatty acid synthase (FAS) activity, molecules involved in "de novo" lipid synthesis, as well as Ppar-α and Cpt-1 mRNA levels together with carnitine palmitoyltransferase 1 (CPT-1) activity, molecules involved in β-oxidation.
The liver showed a significant increase in lipogenic-regulatory proteins and a decrease in β-oxidation-involved molecules in G7, but also in G13, in spite of the hyperleptinemia; the opposite pattern was revealed in G18. These findings parallel the response to leptin observed in this tissue. Indeed, SREBP-1 protein content (both processed and nonprocessed protein) was increased in G7 and G13 (P = 0.029 and 0.043, respectively) and decreased in G18 (P = 0.023) ( Figure 3A) . Furthermore, we found higher levels of Fas mRNA and FAS activity in G13 than in control rats ( Figure 3B : P = 0.001 and P = 0.002), with FAS activity already increased in G7 ( Figure 3B : P = 0.014) and a recovery of Fas mRNA levels in G18. In contrast, Ppar-α and Cpt-1 mRNA levels and CPT-1 activity were significantly reduced in G13 ( Figure 3C : P = 0.012 and 3D: P = 0.008 and P = 0.048), with a recovery in G18 (Figure 3C and  D) .
In SAT, we observed very high levels of FAS activity in G7 and G13 ( Figure 3E : P = 0.000 and P = 0.025), which decrease in G18 ( Figure 3E : P = 0.227 vs G13) and an elevated CPT-1 activity in G13 ( Figure 3G : P = 0.004).
Finally, a significant hypertriglyceridemia was demonstrated in G13 rats (Table 1 : P = 0.002).
Our data suggest that the increase in lipogenesis starts early in pregnancy and is maintained in mid-term, in the presence of central [5] but also peripheral resistance to the hyperleptinemia. In late pregnancy, a recovery of the peripheral response to leptin is observed, while the central resistance still continues [5] , and a change in metabolism toward a catabolic state appears.
Role of maternal hormones on the peripheral leptin resistance during pregnancy
To evaluate the possible role of maternal versus placental hormones in the resistance to leptin in the periphery during pregnancy, we used rats of 9 days of pseudogestation (P9), a state of prolonged secretion of the corpus luteum, and therefore with similar hormonal characteristics to those in the first half of pregnancy in the rat. After 18 days of pseudogestation (P18), rats have returned to estrous cyclicity. To demonstrate the state of pseudopregnancy, we determined serum progesteron levels in P9 rats and compared them with the levels in nonpregnant, G13 and G18, and P18 animals. We found similar higher levels of progesterone in P9, G13, and G18 rats, which returned to nonpregnant values in P18 (Figure 4 : P = 0.004, P = 0.001, and P = 0.002, respectively).
We studied in P9 and P18 rats the response of the STAT3 signaling pathway to iv leptin administration (100 μg/rat) in liver and SAT, as well as the levels of LepRb mRNA and SOCS3 protein in both tissues. As shown in Figure 5 , a normal response to leptin was demonstrated in pseudopregnant rats, assessed as phosphorylation levels of STAT3 ( Figure 5A : CL: P = 0.001; P9L: P = 0.001 and 5D: CL: P = 0.001; P9L: P = 0.001; P18L: P = 0.001). Furthermore, no changes were observed in LepRb mRNA ( Figure 5B ) or SOCS3 protein levels ( Figure 5C ) between control and pseudopregnant animals. We were also unable to find significant differences in Srebp-1 and Fas mRNA levels and FAS activity, or in Ppar-α and Cpt-1 mRNA levels or CPT-1 activity in the liver and SAT of pseudopregnant rats in relation to nonpregnant animals ( Figure 6A-F) . Finally, no changes were observed in the levels of serum triglycerides in P9 in comparison to controls, but they were lower than those observed in G13 (Table 1 : P = 0.002, P9 vs G13).
These results reflect that progesterone and prolactin do not seem to be responsible for the resistance to leptin in the periphery, or the increased lipogenic activity observed during mid-term rat gestation.
Discussion
One of the adaptations that the mother needs to evolve to cope successfully with pregnancy is the regulation of her metabolism to be able to supply nutrients to the fetus and establish a positive energy balance to deposit energy stores for metabolic demands of gestation and lactation. In both rodents and humans, the two main manifestations of the modified maternal lipid metabolism during normal pregnancy are the accumulation of lipids as a result of changes in adipose tissue metabolism and the increase in lipid synthesis, especially in the liver. Circulating triglycerides and VLDL triglyceride levels are highly augmented in the pregnant rat, indicating that liversynthesized triglycerides are rapidly released into the circulation [3, 41, 42] . The increase in lipid synthesis and fat deposits takes place during the first two-thirds of gestation, in the presence of a progressive increase of circulating leptin levels [5, 6] , which reflects a state of resistance to leptin or the existence of other more critical mechanisms that increase body fat overcoming the lipolytic effect of hyperleptinemia. Previous data from us and other authors have demonstrated that pregnancy is a physiological state of leptin resistance at the central level [1, [5] [6] [7] [8] , which allows hyperphagia and probably some of the anabolic changes observed during this state. Although the most important and well-defined effects of leptin are mediated by hypothalamic receptors [11] , leptin receptors are also expressed in a wide variety of peripheral organs, including liver, adipose tissue, skeletal muscle, and pancreas [13, 14, 43, 44] , with functions in the regulation of lipid and carbohydrate metabolism within these target tissues [13, 21, 22, 44] . In order to evaluate the existence of leptin resistance in the periphery during gestation, we studied the main signaling cascades activated by the iv injection of leptin, as well as the levels of LepRb mRNA and the protein levels of SOCS3 in mid-term (G13) and in late (G18) pregnant rats. We chose these gestational ages because we had previously demonstrated that hyperleptinemia and central leptin resistance are already established in G13 and are maintained throughout pregnancy [5] . As we were interested mainly in lipid metabolism, we focused our attention on two specific organs: liver and adipose tissue. In these tissues, we were able to demonstrate a blockade of STAT3 and PI3K/AKT Table 1 . Serum triglyceride levels in rats. pathways in response to leptin in G13, suggesting the existence of leptin resistance during mid-pregnancy also in the periphery, and a recovery of the response in G18. This biphasic response to leptin in the periphery differs from the lack of central response to leptin in both mid-term and late pregnancy [5] . Furthermore, the decreased basal levels of pSTAT3 and pAKT in liver and adipose tissue in G13 probably indicate that more than one mechanism is involved. A putative role of insulin in the low basal pAKT levels should be discarded. The decreased leptin receptor expression and the increased levels of SOCS3 at mid-gestation (G13) constitute plausible causes of the blunted response of STAT3 and PI3K/AKT cascades, although a more detailed molecular study of the early events in the signaling cascade including phosphorylation of JAK2 and LepRb at the different gestational ages will shed more light into this process. The study of the levels of protein tyrosine phosphatases, important players in leptin resistance, by suppressing leptin signaling also merits evaluation. We still do not know the factors inducing the increase in SOCS3 during pregnancy, but the fact that SOCS3 levels appeared elevated in G13, when animals become or are insensitive to leptin and exhibit a reduced leptin-induced STAT3 phosphorylation reasonably, suggests that the increase in SOCS3 during mid-pregnancy is mediated by a different signal from leptin. The leptin resistance mechanisms reported in this manuscript have already been shown in central leptin resistance during pregnancy, diet-induced obesity, and seasonal animals [5, 45, 46] .
As peripheral leptin plays an important role in controlling lipid metabolism by inhibiting synthesis of triacylglycerol and promoting lipolysis and β-oxidation in organs like adipose tissue and liver [13] [14] [15] 43] , we studied key molecules involved in lipid metabolism in these tissues in G7, G13, and G18. We observed that lipogenic activity is already increased in early pregnancy and keeps elevated in mid-gestation, despite the hyperleptinemia. In late gestation, a catabolic pattern appears. This biphasic profile parallels the pattern of leptin responsiveness observed in these organs. All this may suggest that the peripheral resistance to leptin in mid-term contributes to maintain the early enhanced lipogenesis and fat deposit when the levels of circulating leptin increase; the recovery of the response to leptin in late gestation, when serum leptin levels are still very high, would favor a catabolic metabolism.
The white adipocytes are cells able to perform two apparently opposite functions simultaneously. They can accumulate triglycerides but at the same time they release leptin at concentrations that can burn fat when these levels are induced in thin rodents and in ob/ob mice. The increase in fat during gestation in the presence of progressively higher levels of leptin probably reflects a blockade in leptin action. Our results indicate that these mechanisms of resistance to leptin in the adipose tissue start very early in pregnancy. Indeed, LepRb mRNA levels in this tissue are already reduced on the seventh day of gestation, when serum leptin levels are not significantly increased yet [5, 47] . In liver, the reduction does not happen till G13. Also, central leptin resistance does not begin until mid-pregnancy. This early state of leptin resistance in SAT might contribute to the enormous increase in FAS activity observed in this tissue at this gestational age, favoring lipogenesis and fat deposit.
Although in this work we have worked only with subcutaneous fat (SAT), numerous reports have shown differences in gene expression and regulation between SAT and visceral fat in nonpregnant and pregnant rodents and human [48, 49] . A more detailed analysis of the response to leptin and of the differences in the metabolism in both types of fat during pregnancy is needed and deserves more investigation.
Although our data support that the changes observed in the key molecules involved in lipid metabolism in both liver and adipose tissue during pregnancy might be due to peripheral leptin resistance, we cannot exclude that the effect can be also partly indirect, mediated by the hypothalamus or the result of the interaction of leptin with other hormones. Furthermore, although the increase in lipid synthesis and fat deposits that takes place during the first half of gestation suggests a state of leptin resistance, we cannot discard the existence of other more critical mechanisms that increase body fat overcoming the lipolytic effect of hyperleptinemia. The role of insulin and its interaction with leptin should be evaluated. Of note, an enhanced insulin responsiveness of adipocytes in early pregnancy has been previously shown [47] , which likely contribute to maternal fat accumulation during early gestation. Whether the augmented adipose tissue responsiveness to the anti-lipolytic action of insulin at early pregnancy is also related to the early decrease of leptin receptor levels in this tissue, as it has been shown for ß3-adrenergic receptor protein and activity [47] remains to be determined. Late gestation constitutes, in contrast, a state of insulin resistance [47] . The molecular events and signals responsible for the responsiveness and resistance of insulin by adipocytes throughout pregnancy and the interplay with leptin and other maternal and placental hormones are not completely understood and merit further investigation but go beyond the scope of our manuscript.
The responsible factors for this peripheral leptin resistance are still unknown, but the increase of progesterone and prolactin does not seem to play an important role in these mechanisms, as it has been demonstrated by our results with the model of pseudogestation. This model has been used formerly by our group to be able to evaluate the effects of the main maternal hormones without the action of the placenta [5] . Our data indicate that progesterone and prolactin are not the main factors responsible for the peripheral leptin resistance and the lipid metabolic adaptations reported here in mid-pregnant rats. The development of the placenta and the appearance of placental hormones around mid-gestation, especially the placental lactogens, might play an important role. Also the fact that the placenta synthesizes the soluble leptin receptor should be taken into consideration [6, 50] . Finally, the state of hyperleptinemia itself can contribute to leptin resistance by downregulating the cellular response to leptin [51] , as it has been shown for other hormones. All these issues require further investigation.
Although in vitro experiments would have been complementary to our in vivo data, we consider that our results showing reduced STAT3 phosphorylation in response to leptin iv administration greatly support the evidence of a direct reduction of leptin responsiveness in liver and adipose tissue during mid-pregnancy.
In conclusion, our data demonstrate that pregnancy exhibits a biphasic response to the hyperleptinemia of mid-and late gestation: a state of peripheral leptin resistance in midpregnancy to help maintaining the enhanced synthesis and deposit of lipids, and the reappearance of leptin responsiveness in advance pregnancy, which probably benefits the catabolic metabolism.
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